Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 7.91 is 59% above its 5-year average of 4.98, around the middle of its 5-year range (3.26–15.01).
As of the fiscal period ended Tuesday, June 30, 2026. 33.52% above its 12-month average of 5.92.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.91.
CURRENT RATIO
7.91
CURRENT RATIO AVG TTM
5.92
CURRENT RATIO AVG 3Y
4.61
CURRENT RATIO AVG 5Y
4.98
CURRENT RATIO AVG 10Y
5.35
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+33.52%
CURRENT VS 3Y AVG
+71.46%
CURRENT VS 5Y AVG
+58.67%
CURRENT VS 10Y AVG
+47.84%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.40
median of 636 covered companies
CURRENT VS SECTOR MEDIAN
+132.86%
vs the sector median at left
Market Cap
$473.97M
Current Ratio
121.97
TTM Avg
23.71
3Y Avg
19.95
5Y Avg
19.50
Market Cap
$471.77M
Current Ratio
37.17
TTM Avg
24.09
3Y Avg
19.47
5Y Avg
19.38
Market Cap
$450.87M
Current Ratio
6.72
TTM Avg
10.04
3Y Avg
13.74
5Y Avg
16.43
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arvinas, Inc. (ARVN) | $473.91M | 7.91 | 5.92 | 4.61 | 4.98 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $473.97M | 121.97 | 23.71 | 19.95 | 19.50 |
| Cerus Corporation (CERS)vs › | $469.55M | 1.83 | 2.06 | 1.93 | 2.19 |
| Evolus, Inc. (EOLS)vs › | $482.72M | 1.70 | 2.15 | 2.20 | 2.10 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $471.77M | 37.17 | 24.09 | 19.47 | 19.38 |
| NRC Health (NRC)vs › | $461.11M | 0.65 | 0.55 | 0.77 | 1.10 |
| Kamada Ltd. (KMDA)vs › | $455.78M | 4.06 | 3.90 | 3.27 | 3.77 |
| Oculis Holding AG (OCS)vs › | $494.52M | 8.35 | 4.17 | 3.90 | 4.80 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $450.87M | 6.72 | 10.04 | 13.74 | 16.43 |
| Allogene Therapeutics, Inc. (ALLO)vs › | $501.86M | 10.72 | 8.23 | 9.67 | 9.58 |
Current Ratio
7.91
Quick Ratio
7.91
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 7.91 |
| 2026-03-31 | 5.44 |
| 2025-12-31 | 4.92 |
| 2025-09-30 | 5.70 |
| 2025-06-30 | 5.64 |
| 2025-03-31 | 4.58 |
| 2024-12-31 | 4.64 |
| 2024-09-30 | 4.17 |
| 2024-06-30 | 3.62 |
| 2024-03-31 | 4.94 |
| 2023-12-31 | 4.98 |
| 2023-09-30 | 3.26 |
| 2023-06-30 | 3.44 |
| 2023-03-31 | 4.06 |
| 2022-12-31 | 4.20 |
| 2022-09-30 | 5.33 |
| 2022-06-30 | 5.78 |
| 2022-03-31 | 6.12 |
| 2021-12-31 | 5.93 |
| 2021-09-30 | 8.64 |
| 2021-06-30 | 15.01 |
| 2021-03-31 | 16.46 |
| 2020-12-31 | 14.29 |
| 2020-09-30 | 6.53 |
| 2020-06-30 | 7.40 |
| 2020-03-31 | 8.15 |
| 2019-12-31 | 8.86 |
| 2019-09-30 | 6.79 |
| 2019-06-30 | 7.79 |
| 2019-03-31 | 8.72 |
| 2018-12-31 | 8.52 |
| 2018-09-30 | 4.81 |
| 2018-06-30 | 5.99 |
| 2018-03-31 | 6.63 |
| 2017-12-31 | 3.67 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
